Free Shipping on orders over $250
Product Name
PNC-27
$125.00
An experimental chimeric peptide investigated for p53/HDM-2 interactions, membrane-associated protein biology, and peptide-mediated pore-formation mechanisms.
Research Focus
p53–HDM-2 Interactions • Membrane HDM-2 • Peptide–Protein Binding • Plasma-Membrane Biology • Transmembrane Pore Formation • Cellular Signaling
Research Disclaimer: Avante Peptides products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.
PNC-27 is an experimental 32-amino-acid chimeric research peptide containing a sequence derived from the HDM-2-binding region of the p53 protein linked to a membrane-active peptide sequence.
Laboratory and preclinical research involving PNC-27 has examined p53–HDM-2 molecular interactions, membrane-associated HDM-2, peptide–protein binding, plasma-membrane dynamics, transmembrane pore formation, and membrane-disruption mechanisms. Experimental cellular studies have investigated how the peptide’s p53-derived domain interacts with membrane-associated HDM-2 and how this interaction influences membrane structure.
PNC-27 remains an experimental research compound for investigating p53/HDM-2 biology, membrane-associated protein interactions, peptide-mediated pore formation, and cellular membrane mechanisms.
| Attributes | Value |
|---|---|
| Dimensions | 0.66 × 0.66 × 1.5 in |
| Strength |
10mg |
| Research Focus |
p53–HDM-2 Interactions • Membrane HDM-2 • Peptide–Protein Binding • Plasma-Membrane Biology • Transmembrane Pore Formation • Cellular Signaling |